Universal-Beteiligungs- und Servicegesellschaft’s Kymera Therapeutics KYMR Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Sell	89,494 -13,706	-13%	-$1.18M	0.02%	646
2026 Q1	$8.6M	Sell	103,200 -2,354	-2%	-$186K	0.01%	663
2025 Q4	$8.21M	Sell	105,554 -2,149	-2%	-$145K	0.01%	681
2025 Q3	$6.1M	Buy	107,703 +265	+0.2%	+$12K	0.01%	787
2025 Q2	$4.69M	Buy	107,438 +22,392	+26%	+$771K	0.01%	857
2025 Q1	$2.33M	Sell	85,046 -29,541	-26%	-$1.08M	﹤0.01%	1116
2024 Q4	$4.61M	Buy	+114,587	New	+$5.18M	0.01%	727

Other funds holding KYMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's KYMR Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Kymera Therapeutics (KYMR) stake by 13% in Q2 2026, selling an estimated $1.18M and leaving 89,494 shares worth $10.3M. The position accounts for 0.02% of the portfolio, ranked #646.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in KYMR in Q4 2024 and has held it in 7 quarters since. 141 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 89,494 shares of Kymera Therapeutics worth $10.3M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 13,706 Kymera Therapeutics shares in Q2 2026, an estimated $1.18M.
Kymera Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #646 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Kymera Therapeutics in Q4 2024 and has held it in 7 quarters since.
141 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.